HIV and Influenza: Increased Risk and Severity

People with HIV (PWH) experience higher influenza incidence, severity, and complications, particularly with low CD4 counts or unsuppressed viral load.

Epidemiology

  • 2-4× higher influenza incidence vs. general population
  • 20-100× higher hospitalization rate (varies by CD4)
  • Increased mortality: 9-170× higher (pre-ART era); still elevated with ART
  • Prolonged viral shedding → increased transmission risk

Immunologic Basis

  • CD4+ T-cell depletion → impaired humoral & cellular immunity
  • B-cell dysfunction → reduced vaccine response, impaired neutralizing antibodies
  • Mucosal immunity defects → respiratory barrier compromise
  • Chronic immune activation → inflammatory dysregulation

Clinical Presentation

  • Typical symptoms (fever, cough, myalgia) but often more severe/prolonged
  • Higher rates of: primary viral pneumonia, secondary bacterial pneumonia (S. pneumoniae, S. aureus), exacerbations of underlying lung disease
  • Atypical presentations in advanced HIV: afebrile, GI predominant, CNS involvement

Diagnosis

  • Rapid influenza diagnostic tests (RIDTs): Lower sensitivity in PWH; PCR preferred
  • Multiplex respiratory panels: Detect co-infections (RSV, COVID, bacteria)
  • Chest imaging if pneumonia suspected

Treatment

Start empiric therapy immediately if high suspicion; do not wait for test.

Prevention

  • Annual inactivated influenza vaccine (IIV): Recommended for all PWH
  • High-dose or adjuvanted vaccine: Preferred for >65yo; may enhance immunogenicity in PWH
  • Timing: Before flu season (Sept-Oct in Northern hemisphere)
  • Effectiveness: 30-60% in PWH (lower with CD4<200); still reduces severity
  • Live attenuated (LAIV): Contraindicated in PWH
  • Chemoprophylaxis: Oseltamivir 75mg daily during outbreaks if vaccination contraindicated or post-exposure

Special Considerations

  • Drug interactions: Oseltamivir minimal; check ART interactions (e.g., boosted PIs with other meds)
  • CD4 <200: Add PCP prophylaxis (TMP-SMX) if not on it; consider broader pneumonia coverage
  • Pregnancy: Oseltamivir preferred; vaccine safe any trimester

HIV & AIDS - Related Articles

Health Sciences © https://www.222health.com

AgentDosingNotes
Oseltamivir75mg BID ×5d (adjust for renal function)First-line; start ≤48h ideal; still beneficial if later in severe disease
Zanamivir10mg (2 inhalations) BID ×5dInhaled; avoid in asthma/COPD (bronchospasm risk)
Peramivir600mg IV single doseFor hospitalized/unable to tolerate oral
BaloxavirSingle dose (40mg <80kg, 80mg ≥80kg)Not studied extensively in PWH; avoid with polyvalent cations